Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valerio Mariani

Showing results (11-20 of 140) with videos related to

Pageof 14
Sort By:
Therapeutics and Clinical Risk Management|May 24, 2019
Rivaroxaban in atrial fibrillation cardioversion: an updateCarlo Lavalle, Martina Straito, Annalisa Caroli, et al.
Heart Failure Reviews|August 26, 2019
Correction to: Structural and myocardial dysfunction in heart failure beyond ejection fractionPaolo Severino, Viviana Maestrini, Marco Valerio Mariani, et al.
Heart Failure Reviews|July 19, 2019
Structural and myocardial dysfunction in heart failure beyond ejection fractionPaolo Severino, Viviana Maestrini, Marco Valerio Mariani, et al.
Journal of Cardiovascular Development and Disease|October 25, 2024
Relevance of Anatomical Significance of AV Nodal Structures within Koch's Triangle and PyramidAndrea Matteucci, Claudio Pandozi, Maurizio Russo, et al.
Frontiers in Cardiovascular Medicine|August 23, 2024
Case Report: Epi-endocardial bridges in refractory cavotricuspid isthmus-dependent atrial flutter: technical analysis of epi-endocardial breakthroughAndrea Matteucci, Claudio Pandozi, Maurizio Russo, et al.
Medicina (Kaunas, Lithuania)|November 11, 2022
Incidence and Determinants of Spontaneous Cardioversion of Early Onset Symptomatic Atrial FibrillationMarco Valerio Mariani, Nicola Pierucci, Agostino Piro, et al.
Vascular Pharmacology|February 3, 2024
Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension: A systematic review and network meta-analysisGiovanna Manzi, Marco Valerio Mariani, Domenico Filomena, et al.
Proteins|October 15, 2011
CASP9 target classificationLisa N Kinch, Shuoyong Shi, Hua Cheng, et al.
International Journal of Cardiology|December 29, 2023
Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension: A systematic review and network meta-analysisGiovanna Manzi, Marco Valerio Mariani, Domenico Filomena, et al.
Reviews in Cardiovascular Medicine|April 2, 2026
Hemolysis in Pulsed Field Ablation for Atrial Fibrillation: A Narrative ReviewAngelica Cersosimo, Nicola Pierucci, Marco Valerio Mariani, et al.
Pageof 14

Showing results (11-20 of 140) with videos related to

Sort By:
Pageof 14
Therapeutics and Clinical Risk Management|May 24, 2019
Rivaroxaban in atrial fibrillation cardioversion: an updateCarlo Lavalle, Martina Straito, Annalisa Caroli, et al.
Heart Failure Reviews|August 26, 2019
Correction to: Structural and myocardial dysfunction in heart failure beyond ejection fractionPaolo Severino, Viviana Maestrini, Marco Valerio Mariani, et al.
Heart Failure Reviews|July 19, 2019
Structural and myocardial dysfunction in heart failure beyond ejection fractionPaolo Severino, Viviana Maestrini, Marco Valerio Mariani, et al.
Journal of Cardiovascular Development and Disease|October 25, 2024
Relevance of Anatomical Significance of AV Nodal Structures within Koch's Triangle and PyramidAndrea Matteucci, Claudio Pandozi, Maurizio Russo, et al.
Frontiers in Cardiovascular Medicine|August 23, 2024
Case Report: Epi-endocardial bridges in refractory cavotricuspid isthmus-dependent atrial flutter: technical analysis of epi-endocardial breakthroughAndrea Matteucci, Claudio Pandozi, Maurizio Russo, et al.
Medicina (Kaunas, Lithuania)|November 11, 2022
Incidence and Determinants of Spontaneous Cardioversion of Early Onset Symptomatic Atrial FibrillationMarco Valerio Mariani, Nicola Pierucci, Agostino Piro, et al.
Vascular Pharmacology|February 3, 2024
Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension: A systematic review and network meta-analysisGiovanna Manzi, Marco Valerio Mariani, Domenico Filomena, et al.
Proteins|October 15, 2011
CASP9 target classificationLisa N Kinch, Shuoyong Shi, Hua Cheng, et al.
International Journal of Cardiology|December 29, 2023
Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension: A systematic review and network meta-analysisGiovanna Manzi, Marco Valerio Mariani, Domenico Filomena, et al.
Reviews in Cardiovascular Medicine|April 2, 2026
Hemolysis in Pulsed Field Ablation for Atrial Fibrillation: A Narrative ReviewAngelica Cersosimo, Nicola Pierucci, Marco Valerio Mariani, et al.
Pageof 14